DK115537B - Fremgangsmåde til fremstilling af 6-methyl-Δ<8,9>-ergolen-8-carboxylsyre eller lysergsyre. - Google Patents

Fremgangsmåde til fremstilling af 6-methyl-Δ<8,9>-ergolen-8-carboxylsyre eller lysergsyre.

Info

Publication number
DK115537B
DK115537B DK425464AA DK425464A DK115537B DK 115537 B DK115537 B DK 115537B DK 425464A A DK425464A A DK 425464AA DK 425464 A DK425464 A DK 425464A DK 115537 B DK115537 B DK 115537B
Authority
DK
Denmark
Prior art keywords
ergolen
methyl
acid
preparation
carboxylic acid
Prior art date
Application number
DK425464AA
Other languages
English (en)
Inventor
J Rutschmann
H Kobel
E Schreier
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1305363A external-priority patent/CH468465A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK115537B publication Critical patent/DK115537B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/183Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing an indolo[4,3-F,G]quinoleine nucleus, e.g. compound containing the lysergic acid nucleus as well as the dimeric ergot nucleus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK425464AA 1963-08-29 1964-08-28 Fremgangsmåde til fremstilling af 6-methyl-Δ<8,9>-ergolen-8-carboxylsyre eller lysergsyre. DK115537B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1063763 1963-08-29
CH1305363A CH468465A (de) 1963-10-24 1963-10-24 Verfahren zur Gewinnung von 6-Methyl- 8,9-ergolen-8-carbonsäure

Publications (1)

Publication Number Publication Date
DK115537B true DK115537B (da) 1969-10-20

Family

ID=25707024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK425464AA DK115537B (da) 1963-08-29 1964-08-28 Fremgangsmåde til fremstilling af 6-methyl-Δ<8,9>-ergolen-8-carboxylsyre eller lysergsyre.

Country Status (13)

Country Link
US (1) US3314961A (da)
AT (1) AT269364B (da)
BE (1) BE652378A (da)
CS (1) CS149574B2 (da)
DE (1) DE1442294A1 (da)
DK (1) DK115537B (da)
ES (2) ES303518A1 (da)
GB (1) GB1067513A (da)
LU (1) LU46842A1 (da)
MC (1) MC493A1 (da)
NL (1) NL146168B (da)
OA (1) OA00224A (da)
SE (1) SE325035B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH469735A (de) * 1965-11-02 1969-03-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
NL6703461A (da) * 1966-03-10 1967-09-11
EP2141165A1 (de) 2008-06-30 2010-01-06 Sandoz AG Aufarbeitung von mikrobiologisch hergestellten Mutterkornalkaloiden
US9790528B2 (en) 2014-06-16 2017-10-17 West Virginia University Production of lysergic acid by genetic modification of a fungus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2265207A (en) * 1941-12-09 D-lysergic acid - d - l-bjtdroxybutyl
US2796419A (en) * 1954-09-27 1957-06-18 Lilly Co Eli Lysergic acid, intermediates and preparation
US2936266A (en) * 1955-03-03 1960-05-10 Versuchs U Lehranstalt Fur Spi Production of ergot alkaloids
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
US3038840A (en) * 1959-07-07 1962-06-12 Farmaceutici Italia Process for the production of alkaloid derivatives of lysergic acid
US3060104A (en) * 1960-07-19 1962-10-23 Farmaceutici Italia Process for obtaining new alkaloid derivatives of lysergic acids
US3162640A (en) * 1960-12-07 1964-12-22 Farmaceutici Italia Alkaloid derivatives of lysergic acids

Also Published As

Publication number Publication date
ES303518A1 (es) 1965-03-16
US3314961A (en) 1967-04-18
CS149574B2 (da) 1973-07-25
OA00224A (fr) 1966-03-15
LU46842A1 (da) 1965-03-02
DE1442294A1 (de) 1969-03-06
ES307219A1 (es) 1965-04-16
GB1067513A (en) 1967-05-03
NL6409763A (da) 1965-03-01
SE325035B (da) 1970-06-22
NL146168B (nl) 1975-06-16
AT269364B (de) 1969-03-10
MC493A1 (fr) 1965-06-04
BE652378A (da) 1965-03-01

Similar Documents

Publication Publication Date Title
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK108497C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner eller syreadditionssalte deraf.
DK125421B (da) Analogifremgangsmåde til fremstilling af 5-substituerede-aza-dibenzo-cycloheptener eller syreadditionssalte deraf.
DK130070B (da) Analogifremgangsmåde til fremstilling af 3,4-dihydroxyphenylalkanolaminer eller syreadditionssalte deraf.
DK124404B (da) Fremgangsmåde til fremstilling af 2-arylamino-1,3-diazacycloalkener-(2) eller syreadditionssalte deraf.
DK120493B (da) Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.
DK117000B (da) Fremgangsmåde til fremstilling af substituerede phenylamino-1,3-diazacyclopentener-(2) eller syreadditionssalte heraf.
DK112872B (da) Fremgangsmåde til fremstilling af [1,2-α]-imidazopyridiner eller syreadditionssalte deraf.
DK119107B (da) Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ&lt;4,9&gt;-gonadiener.
DK115537B (da) Fremgangsmåde til fremstilling af 6-methyl-Δ&lt;8,9&gt;-ergolen-8-carboxylsyre eller lysergsyre.
DK121120B (da) Fremgangsmåde til fremstilling af 3-hydroxy-Δ&lt;1,5&gt;-androstadiener eller 3-estere eller 3-ethere deraf.
DK108394C (da) Fremgangsmåde til fremstilling af substituerede imidazo- eller pyrimido-quinazoliner eller syreadditionssalte deraf.
DK118231B (da) Fremgangsmåde til fremstilling af 6-methyl-&amp;Delta&lt;8,9&gt;-ergolen-8-carboxylsyre eller lysergsyre.
DK112449B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf.
DK103832C (da) Fremgangsmåde til fremstilling af 4-(N&lt;1&gt;-alkanoylsulfanilamido)-5,6-dimethoxy-pyrimidiner.
DK108211C (da) Fremgangsmåde til fremstilling af Δ&lt;4,9&gt;-estradien-3β,17-dioler eller 3-monoestere, 17-monoestere eller 3,17-diestere heraf.
DK111893B (da) Fremgangsmåde til fremstilling af substituerede methylhydraziner eller syreadditionssalte deraf.
DK105920C (da) Fremgangsmåde til fremstilling af 3-β-hydroxyethylimino-17 α-acyloxy-20-keto-4,6-pregnadien-(eller 1,4,6-pregnatrien)-derivater.
DK104170C (da) Fremgangsmåde til fremstilling af 3-alkoxy- eller 3-aralkoxy-16-amino-Δ&lt;3,5&gt;-pregnadien-17α-ol-20-oner, eller 16-amino-Δ&lt;4&gt;-pregnen-17α-ol-3,20-dioner.
DK116206B (da) Fremgangsmåde til fremstilling af 16α-brom- eller -iod-3,20-dioxo-17α-hydroxy-Δ&lt;4&gt;-pregnener.
DK114827B (da) Fremgangsmåde til fremstilling af 5-keto-11-hydroxy-17β-acyloxy-Δ&lt;9&gt;-des-A-estren eller 5,11-diketo-17β-acyloxy-Δ&lt;9&gt;-des-A-estren.
DK107169C (da) Fremgangsmåde til fremstilling af 10-monoalkylaminoalkyl-10,11-dihydro-11-oxo-5H-dibenzo(b,e)(1,4)diazepiner eller syreadditionssalte deraf.
DK113919B (da) Analogifremgangsmåde til fremstilling af 16α-alkyl-Δ&lt;4,6&gt;-pregnadien-3,20-dioner.
DK107555C (da) Fremgangsmåde til fremstilling af 1,4-benzo-diazepin-4-oxider eller syreadditionssalte deraf.
DK107617C (da) Fremgangsmåde til fremstilling af basisk substituerede 11-alkyl-5,6-dihydro-6-oxo-morphanthridiner eller syreadditionssalte deraf.